Sarah Davis
0000-0002-6609-4287
2 papers found
Refreshing results…
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis
Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
Missing publications? Search for publications with a matching author name.